跳至主要内容
临床试验/NCT07599904
NCT07599904招募中不适用

REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry)

Medtronic Neurovascular Clinical Affairs3 个研究点 分布在 1 个国家目标入组 1,500 人开始时间: 2026年7月13日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,500
试验地点
3

研究概览

简要总结

Post-Market Registry

详细描述

An observational, prospective, multi-center, single-arm registry to provide continuing evaluation of safety and effectiveness of Medtronic Neurovascular commercially available products used in the treatment of acute ischemic stroke.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical requirements.
  • Participant is treated or intended to be treated with a commercially available Medtronic Neurovascular device* during treatment for acute ischemic stroke.
  • Participant is 18 years of age or older.

排除标准

  • Participant who may be unable to complete follow-up within the registry.
  • Participant of child-bearing potential who is known to be pregnant or is breastfeeding or wishes to become pregnant during participation in the study.
  • Participant is currently enrolled in, or plans to enroll in, any concurrent drug/device study that may confound the study results based on Principal Investigator's discretion.

研究者

发起方
Medtronic Neurovascular Clinical Affairs
申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验